Abstract
Purpose
To evaluate the variation of 24-hours blood pressure in patients with normal tension glaucoma (NTG) and primary open-angle glaucoma (POAG).
Methods
Thirty patients with NTG, 30 patients with POAG, and 30 normal controls were enrolled in this study. Each subjects underwent 24-hours ambulatory blood pressure monitoring. The variation of each parameter and difference among NTG, POAG, and control groups were compared.
Results
The lowest diastolic blood pressure (DBP) and the lowest mean arterial blood pressure (MAP) were significantly lower in the NTG group(51.9±11.3 mmHg and 66.9± 13.1 mmHg) than in the POAG group(60.0±11.4 mmHg and 77.8±16.8 mmHg, p=0.048 and 0.024) and the control group(60.1±10.5 mmHg and 77.4±13.3 mmHg, p=0.047 and 0.031) during nighttime. More patients showed a lowest MAP less than 60 mmHg in the NTG group(8 patients, 27%) than in the POAG group(2 patients, 7%) and the control group(2 subjects, 7%, p=0.038 each). In addition, a decrease of more than 15% in DBP was more frequent in NTG group(17 patients, 57%) than in the POAG group(9 patients, 30%) and the control group(9 subjects, 30%, p=0.037 each).
References
1. Armaly MF. Ocular pressure and visual fields. A ten-year follow-up study. Arch Ophthalmol. 1969; 81:25–40.
2. Levens RZ. Low tension glaucoma. a critical review and new material. Surv Ophthalmol. 1980; 24:621–64.
3. Perkins ES. The Bedford glaucoma survey. I . Long-term follow-up of boarderline cases. Br J Ophthalmol. 1973; 57:179–85.
5. Brubaker RF. Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture. Am J Ophthalmol. 1996; 121:473–83.
7. Mcleod SD, West SK, Quigley HA, Fozard JL. A longitudinal study of the relationship between intraocular and blood pressures. Invest Ophthalmol Vis Sci. 1990; 31:2361–6.
8. Armstrong JR, Daily RK, Dobson HL, Girard LJ. The incidence of glaucoma in diabetes mellitus. A comparison with the incidence of glaucoma in the general population. Am J Ophthalmol. 1960; 50:55–63.
9. Mitchell P, Lee AJ, Rochtchina E, Wang JJ. Open-angle glaucoma and systemic hypertension: the blue mountains eye study. J Glaucoma. 2004; 13:319–26.
10. Pradalier A, Hamard P, Sellem E, Bringer L. Migraine and glaucoma: an epidemiologic survey of French ophthalmologists. Cephalalgia. 1998; 18:74–6.
12. Harris A, Rechtman E, Siesky B, et al. The role of optic nerve blood flow in the pathogenesis of glaucoma. Ophthalmol Clin North Am. 2005; 18:345–53.
13. Hayreh SS. Progress in the understanding of the vascular etiology of glaucoma. Curr Opin Ophthalmol. 1994; 5:26–35.
14. Hayreh SS. The blood supply of the optic nerve head and the evaluation of it: myth and reality. Prog Retin Eye Res. 2001; 20:563–93.
15. Gherghel D, Orgul S, Gugleta K, et al. Relationship between ocular perfusion pressure and retrobulbar blood flow in patients with glaucoma with progressive damage. Am J Ophthalmol. 2000; 130:597–605.
16. Sehi M, Flanagan JG, Zeng L, et al. Relative change in diurnal mean ocular perfusion pressure: a risk factor for the diagnosis of primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2005; 46:561–7.
17. Hayreh SS. Duke-elder Lecture. Systemic arterial blood pressure and the eye. Eye. 1996; 10:5–28.
18. Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood pressure. Lancet. 1978; 1:795–7.
19. Pickering T. Recommendations for the use of home (self) and ambulatory blood-pressure monitoring. Am J Hypertens. 1996; 9:1–11.
20. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994; (15):117:603–24.
21. Bechetoille A, Bresson-Dumont H. Diurnal and nocturnal blood pressure drops in patients with focal ischemic glaucoma. Graefes Arch Clin Exp Ophthalmol. 1994; 11:675–9.
22. Plange N, Kaup M, Daneljan L, et al. 24-h blood pressure monitoring in normal tension glaucoma: night-time blood pressure variability. J Hum Hypertens. 2006; 20:137–42.
23. Graham SL, Drance SM, Wijsman K, et al. Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip. Ophthalmology. 1995; 102:61–9.
24. Carenini AB, Sibour G, Boles Carenini B. Differences in the longterm effect of timolol and betaxolol on the pulsatile ocular blood flow. Surv Ophthalmol. 1994; 38:S118–24.
Table 1.
Parameter | NTG | POAG | Control |
p-value |
||
---|---|---|---|---|---|---|
NTG vs POAG | NTG vs Control | POAG vs Control | ||||
Number | 30 | 30 | 30 | |||
Sex (M/F) | 18/12 | 16/14 | 15/15 | 0.602* | 0.436* | 0.796* |
Age (years) | 56.4±10.1 | 58.4±12.4 | 56.0±10.3 | 0.562† | 0.823† | 0.573† |
IOP (mmHg) | 12.9±2.0 | 17.16±7.7 | 14.2±3.3 | 0.061† | 0.127† | 0.179† |
No. of anti-glaucomatous medication | 1.17 | 1.36 | 0 | 0.625† | - | - |
MD (dB) | -11.7±7.0 | -7.9±6.8 | - | 0.148† | - | - |
PSD (dB) | 10.8±4.3 | 6.9±3.7 | - | 0.101† | - | - |
C/D ratio | 0.85±0.15 | 0.86±0.13 | 0.42±0.14 | 0.867† | 0.066† | 0.078† |
Diabetes mellitus | 5 | 9 | 6 | 0.222* | 0.739* | 0.371* |
Hypertension | 7 | 13 | 7 | 0.100* | 1.000* | 0.100* |
Table 2.
Parameter | NTG(n=30) | POAG(n=30) | Control(n=30) |
p-value* |
||
---|---|---|---|---|---|---|
NTG vs POAG | NTG vs Control | POAG vs Control | ||||
Systolic blood pressure (SBP, mmHg) | ||||||
highest SBP | 172.1±28.7 | 169.5±19.0 | 165.0±18.4 | 0.741 | 0.162 | 0.420 |
lowest SBP | 103.8±15.0 | 110.9±15.8 | 107.8±15.2 | 0.162 | 0.343 | 0.316 |
mean SBP | 132.8±13.5 | 137.3±17.2 | 131.3±14.3 | 0.321 | 0.723 | 0.209 |
variability index of SBP | 15.3±5.8 | 13.4±3.5 | 13.0±4.9 | 0.254 | 0.231 | 0.815 |
Diastolic blood pressure (DBP, mmHg) | ||||||
highest DBP | 124.5±22.8 | 114.7±20.0 | 112.4±19.5 | 0.113 | 0.078 | 0.497 |
lowest DBP | 61.0±10.6 | 65.2±10.9 | 64.6±9.9 | 0.145 | 0.216 | 0.795 |
mean DBP | 82.9±9.4 | 87.0±12.1 | 86.0±10.3 | 0.262 | 0.328 | 0.783 |
variability index of DBP | 12.7±5.6 | 10.5±4.5 | 10.9±5.1 | 0.137 | 0.244 | 0.787 |
Heart rate (HR, rate/min) | ||||||
highest HR | 125.9±27.1 | 118.2±28.3 | 115.2±26.8 | 0.443 | 0.126 | 0.559 |
lowest HR | 53.5±8.2 | 53.0±13.4 | 56.3±9.0 | 0.775 | 0.335 | 0.317 |
mean HR | 72.8±7.5 | 73.5±12.0 | 74.2±8.7 | 0.721 | 0.376 | 0.711 |
variability index of HR | 15.0±7.4 | 14.3±7.1 | 13.7±6.8 | 0.652 | 0.356 | 0.638 |
Mean arterial blood pressure (MAP, mmHg) | ||||||
highest MAP | 138.9±21.4 | 128.5±18.1 | 128.3±19.6 | 0.104 | 0.100 | 0.837 |
lowest MAP | 74.7±11.3 | 80.1±11.4 | 80.2±11.2 | 0.233 | 0.224 | 0.879 |
mean MAP | 99.5±10.0 | 103.8±14.8 | 101.1±11.7 | 0.271 | 0.725 | 0.559 |
variability index of MAP | 13.0±5.8 | 10.9±3.5 | 10.5±4.2 | 0.095 | 0.087 | 0.773 |
Table 3.
Parameter | NTG (n=30) | POAG(n=30) | Control(n=30) |
p-value* |
||
---|---|---|---|---|---|---|
NTG vs POAG | NTG vs Control | POAG vs Control | ||||
Systolic blood pressure (SBP, mmHg) | ||||||
highest SBP | 172.1±28.7 | 169.5±19.0 | 165.0±18.4 | 0.741 | 0.162 | 0.420 |
lowest SBP | 103.8±15.0 | 110.9±15.8 | 107.8±15.2 | 0.162 | 0.343 | 0.316 |
mean SBP | 132.8±13.5 | 137.3±17.2 | 131.3±14.3 | 0.321 | 0.723 | 0.209 |
variability index of SBP | 15.3±5.8 | 13.4±3.5 | 13.0±4.9 | 0.254 | 0.231 | 0.815 |
Diastolic blood pressure (DBP, mmHg) | ||||||
highest DBP | 124.5±22.8 | 114.7±20.0 | 112.4±19.5 | 0.113 | 0.078 | 0.497 |
lowest DBP | 61.0± 10.6 | 65.2±10.9 | 64.6±9.9 | 0.145 | 0.216 | 0.795 |
mean DBP | 82.9±9.4 | 87.0±12.1 | 86.0± 10.3 | 0.262 | 0.328 | 0.783 |
variability index of DBP | 12.7±5.6 | 10.5±4.5 | 10.9±5.1 | 0.137 | 0.244 | 0.787 |
Heart rate (HR, rate/min) | ||||||
highest HR | 125.9±27.1 | 118.2±28.3 | 115.2±26.8 | 0.443 | 0.126 | 0.559 |
lowest HR | 53.5±8.2 | 53.0±13.4 | 56.3±9.0 | 0.775 | 0.335 | 0.317 |
mean HR | 72.8±7.5 | 73.5±12.0 | 74.2±8.7 | 0.721 | 0.376 | 0.711 |
variability index of HR | 15.0±7.4 | 14.3±7.1 | 13.7±6.8 | 0.652 | 0.356 | 0.638 |
Mean arterial blood pressure (MAP, mmHg) | ||||||
highest MAP | 138.9±21.4 | 128.5±18.1 | 128.3±19.6 | 0.104 | 0.100 | 0.837 |
lowest MAP | 74.7±11.3 | 80.1±11.4 | 80.2±11.2 | 0.233 | 0.224 | 0.879 |
mean MAP | 99.5± 10.0 | 103.8±14.8 | 101.1±11.7 | 0.271 | 0.725 | 0.559 |
variability index of MAP | 13.0±5.8 | 10.9±3.5 | 10.5±4.2 | 0.095 | 0.087 | 0.773 |
Table 4.
Parameter | NTG (n=30) | POAG (n=30) | Control (n=30) |
p-value* |
||
---|---|---|---|---|---|---|
NTG vs POAG | NTG vs Control | POAG vs Control | ||||
Lowest MAP < 60 mmHg | 8 (27%) | 2 (7%) | 2 (7%) | 0.038 | 0.038 | 1.000 |
Lowest MAP < 65 mmHg | 12 (40%) | 6 (20%) | 6 (20%) | 0.091 | 0.091 | 1.000 |
Lowest MAP < 70 mmHg | 17 (57%) | 10 (33%) | 11 (37%) | 0.069 | 0.121 | 0.787 |
Table 5.
Parameter | NTG (n=30) | POAG (n=30) | Control (n=30) |
p-value* |
||
---|---|---|---|---|---|---|
NTG vs POAG | NTG vs Control | POAG vs Control | ||||
Night time systolic dip (%) | 13.0±5.3 | 11.1±7.8 | 8.0±5.7 | 0.259 | 0.053 | 0.219 |
Night time diastolic dip (%) | 15.4±6.1 | 11.6±7.0 | 11.5±6.0 | 0.068 | 0.066 | 0.871 |
Night time MAP dip (%) | 14.4±5.7 | 11.5±7.5 | 10.0±5.9 | 0.197 | 0.061 | 0.427 |
Table 6.
Parameter | NTG (n=30) | POAG (n=30) | Control (n=30) |
p-value* |
||
---|---|---|---|---|---|---|
NTG vs POAG | NTG vs Control | POAG vs Control | ||||
SBP dipper group | 11 (37%) | 8 (27%) | 9 (30%) | 0.405 | 0.584 | 0.774 |
DBP dipper group | 17 (57%) | 9 (30%) | 9 (30%) | 0.037 | 0.037 | 1.000 |
MAP dipper group | 13 (43%) | 9 (30%) | 9 (30%) | 0.284 | 0.284 | 1.000 |
Table 7.
Parameter | With beta-blocker (n=16) | Without beta-blocker (n=14) | p-value* |
---|---|---|---|
Systolic blood pressure (SBP, mmHg) | |||
highest SBP | 167.7±19.2 | 171.3±18.8 | 0.665 |
lowest SBP | 111.8±16.2 | 110.0±15.4 | 0.821 |
mean SBP | 137.0±17.6 | 137.6±16.8 | 0.892 |
variability index of SBP | 13.6±3.4 | 13.2±3.6 | 0.764 |
Diastolic blood pressure (DBP, mmHg) | |||
highest DBP | 115.9±20.9 | 113.5±19.1 | 0.712 |
lowest DBP | 63.3± 10.7 | 67.1± 11.1 | 0.214 |
mean DBP | 88.3± 12.0 | 85.7±12.2 | 0.727 |
variability index of DBP | 10.4±4.5 | 10.6±4.5 | 0.924 |
Heart rate (HR, rate/min) | |||
highest HR | 115.7±27.2 | 120.7±29.4 | 0.287 |
lowest HR | 52.2±13.1 | 53.8±13.7 | 0.746 |
mean HR | 71.9±13.4 | 75.1±10.6 | 0.508 |
variability index of HR | 14.7±8.0 | 13.9±6.2 | 0.776 |
Mean arterial blood pressure (MAP, mmHg) | |||
highest MAP | 130.0±18.8 | 127.0±17.4 | 0.693 |
lowest MAP | 79.5±11.7 | 80.7± 11.1 | 0.885 |
mean MAP | 104.5±14.2 | 103.0±15.4 | 0.852 |
variability index of MAP | 10.1±3.6 | 11.7±3.4 | 0.749 |
Table 8.
Parameter | With beta-blocker (n=16) | Without beta-blocker (n=14) | p-value* |
---|---|---|---|
Systolic blood pressure (SBP, mmHg) | |||
highest SBP | 139.7±19.5 | 137.5±18.3 | 0.789 |
lowest SBP | 104.5±15.5 | 104.9±16.5 | 0.908 |
mean SBP | 120.8±16.7 | 123.2±17.1 | 0.761 |
variability index of SBP | 11.5±5.7 | 10.9±5.3 | 0.852 |
Diastolic blood pressure (DBP, mmHg) | |||
highest DBP | 91.5±18.0 | 91.9±18.2 | 0.911 |
lowest DBP | 58.7±11.9 | 61.3±10.9 | 0.645 |
mean DBP | 76.0±11.8 | 77.8±11.6 | 0.823 |
variability index of DBP | 9.7±4.5 | 9.3±4.3 | 0.891 |
Heart rate (HR, rate/min) | |||
highest HR | 77.9±19.3 | 81.1±19.9 | 0.671 |
lowest HR | 50.2±11.2 | 51.0±10.8 | 0.919 |
mean HR | 61.1±11.5 | 62.3±12.3 | 0.874 |
variability index of HR | 8.6±4.0 | 8.8±3.8 | 0.892 |
Mean arterial blood pressure (MAP, mmHg) | |||
highest MAP | 105.5±18.5 | 106.7±18.3 | 0.884 |
lowest MAP | 76.9±15.9 | 78.7± 17.7 | 0.827 |
mean MAP | 90.9±12.5 | 92.9±11.9 | 0.766 |
variability index of MAP | 9.8±4.2 | 9.6±3.8 | 0.878 |